Growth Metrics

Fulgent Genetics (FLGT) Cost of Revenue (2016 - 2026)

Fulgent Genetics' Cost of Revenue history spans 12 years, with the latest figure at $49.6 million for Q1 2026.

  • On a quarterly basis, Cost of Revenue rose 10.04% to $49.6 million in Q1 2026 year-over-year; TTM through Mar 2026 was $269.9 million, a 8511.81% increase, with the full-year FY2025 number at $191.8 million, up 429.15% from a year prior.
  • Cost of Revenue hit $49.6 million in Q1 2026 for Fulgent Genetics, down from $159.4 million in the prior quarter.
  • Over the last five years, Cost of Revenue for FLGT hit a ceiling of $159.4 million in Q4 2025 and a floor of -$95.6 million in Q4 2024.
  • Historically, Cost of Revenue has averaged $29.6 million across 5 years, with a median of $12.3 million in 2025.
  • Biggest five-year swings in Cost of Revenue: soared 1452.02% in 2022 and later crashed 311.25% in 2024.
  • Tracing FLGT's Cost of Revenue over 5 years: stood at $10.3 million in 2022, then soared by 341.59% to $45.3 million in 2023, then tumbled by 311.25% to -$95.6 million in 2024, then skyrocketed by 266.66% to $159.4 million in 2025, then crashed by 68.85% to $49.6 million in 2026.
  • Business Quant data shows Cost of Revenue for FLGT at $49.6 million in Q1 2026, $159.4 million in Q4 2025, and $48.6 million in Q3 2025.